FIELD: biotechnology.
SUBSTANCE: invention relates to novel strains of Bacillus thuringiensis B-1272 and Bacillus thuringiensis B-1273 deposited in the collection of bacteria, bacteriophages and fungi of the Federal State-Funded Institution of Science "State Research Centre of Virology and Biotechnology "Vector". The index of neutralisation of the infectious activity of virus A/H3N2 while using the preparations based on the culture fluid of any of the proposed strains is 0.5-3.2 lg.
EFFECT: strains have the ability to neutralise the infectious activity of the human influenza virus.
2 cl, 1 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL MEDICATION (VERSIONS) | 2009 |
|
RU2412238C2 |
ANTIVIRAL MEDICATION BASED ON NEMATOPHAGOUS FUNGUS Duddingtonia flagrans | 2011 |
|
RU2475531C2 |
Bacillus thuringiensis BACTERIA STRAIN EXHIBITING ANTIVIRAL AND ANTI-CANDIDA ACTIVITY (VERSIONS) | 2009 |
|
RU2405035C1 |
STRAIN OF BACTERIA Serratia species WHICH IS PRODUCER OF EXTRACELLULAR RIBONUCLEASE AND DEOXYRIBONUCLEASE HAVING ANTIVIRAL ACTIVITY | 2013 |
|
RU2528064C1 |
ANTIVIRAL AGENT BASED ON SERRATIA-FAMILY BACTERIA NUCLEASE | 2014 |
|
RU2580242C2 |
ANTIVIRAL AGENT BASED ON DRY EXTRACT OF FRUIT BODY OF XYLOTROPHIC BASIDIOMYCETES Bjerkandera adusta | 2015 |
|
RU2580296C1 |
STRAIN OF BACTERIA Serratia plymuthica HAVING ANTIVIRAL ACTIVITY AGAINST INFLUENZA VIRUS OF TYPE A (VERSIONS) | 2013 |
|
RU2551316C1 |
STRAIN OF SERRATIA SPECIES BACTERIA HAVING ANTIVIRAL ACTIVITY | 2017 |
|
RU2650762C1 |
ANTIVIRAL AGENT BASED ON TOTAL AMOUNT OF FLAVONOIDS FROM Alchemilla vulgaris L | 2015 |
|
RU2580304C1 |
MELANINE ANTIVIRAL AGENT | 2011 |
|
RU2480227C2 |
Authors
Dates
2015-05-20—Published
2013-12-30—Filed